Mi SciELO
Servicios Personalizados
Articulo
Indicadores
- Citado por SciELO
Links relacionados
- Similares en SciELO
Compartir
Revista Archivo Médico de Camagüey
versión On-line ISSN 1025-0255
Resumen
GARCIA RODRIGUEZ, Miguel Emilio et al. Use of intrapleural recombinant streptokinase in a pregnant woman with pleural empyema. AMC [online]. 2018, vol.22, n.5, pp. 767-780. ISSN 1025-0255.
Background:
pneumonia complicates 0,78-2,7 per 1 000 pregnancies placing the mother and the fetus at risk. Empyema as a complication of pneumonia in a pregnant patient adds a high rate of morbidity and mortality to the mother and the fetus if one does not act quickly.
Objective:
to present the case of a pregnant woman of 33 weeks who developed a pleural empyema resulting from acquired pneumonia.
Clinical case:
33-week gestated patient, asthmatic admitted to the intensive care unit of the University Hospital Manuel Ascunce Domenech with the diagnosis of severe pneumonia acquired in the community complicated with para-pneumonic effusion, which evolved into empyema. It was treated with a thoracotomy tube and fibrinolytic therapy, with good clinical and radiological evolution.
Conclusions:
Recombinant streptokinase can be used safely and effectively for the management of PE, as an intrapleural fibrinolytic agent, during pregnancy.
Palabras clave : PREGNANCY COMPLICATIONS; STREPTOKINASE/therapeutic use; EMPYEMA, PLEURAL/DRUG THERAPY; EMPYEMA, PLEURAL/ complications; FIBRINOLYTIC AGENTS/therapeutic use.